GlobalData

Some of the key unmet needs in the MDD market are for products that have improved efficacy and safety profiles and that can show…

Therapies with longer treatment intervals are a dominant trend in the AMD pipeline

In November 2023, the Indian Union Health Ministry authorised the sale of four generic medications for the treatment of rare…

These therapies promise life-changing treatments for a broad spectrum of complex diseases ranging from genetic conditions to…

RAG-01 has shown promising results in preclinical tumor suppression and a solid safety profile

The Korean Ministry of Food and Drug Safety (MFDS) has recently mandated the reporting of any suspected adverse reactions,…

The collaboration is poised to help reshape the landscape of drug development and improve the way new therapeutic compounds are…

In December 2022, the company successfully concluded raising a total of $309 million following positive topline data from the…

A better alternative strategy to penetrate the saturated ADHD market would be to target key unmet needs in ADHD treatment such as…

Earlier this year, Pfizer acquired ADC giant Seagen for $43 billion in one of the largest M&A deals in industry history